<DOC>
	<DOCNO>NCT02412553</DOCNO>
	<brief_summary>The study propose 2-year single site , open-label clinical trial enteral nutrition specific carbohydrate diet patient active CD UC . Patients seek care outpatient clinic Division Gastroenterology Massachusetts General Hospital approach participation trial routine outpatient appointment . All patient require diagnosis CD UC confirm use standard clinical , endoscopic , histologic criterion . Eligible patient complete office visit confirm eligibility study inform consent obtain . They schedule routine colonoscopy part standard clinical care objectively confirm active disease obtain biopsy microbiome gene expression . The investigator obtain prior authorization subject 's insurance company colonoscopy , cover insurance , investigator use study fund pay procedure . They assign one two dietary intervention arm base preference meet study register dietician MGH Clinical Research Center ( CRC ) metabolism nutrition unit . There , receive instruction component assign dietary therapy arm - partial elemental diet ( enteral nutrition ) specific carbohydrate diet , complete baseline food record ( FR ) . They adhere dietary therapy 6 week resume normal diet . Clinical , biochemical , nutritional , microbiological parameter measure 6 week follow study . They 5 study visit time .</brief_summary>
	<brief_title>Dietary Therapy Gut Microbiome Crohn 's Disease Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>1 . At least 18 year age 2 . Able provide write informed consent prior screen comply requirement study protocol . 3 . Established diagnosis small bowel colonic CD ulcerative colitis 4 . Confirmation active CD UC recent ( within 1 month ) objective evidence active disease colonoscopy 5 . Any medication currently use IBD must remain stable study period exception taper corticosteroid . 6 . Current disease activity define Harvey Bradshaw index &gt; 4 baseline ( week 0 ) SCCAI &gt; 3 1 . If female , pregnant breast feed 2 . Known celiac disease subject positive screen celiac disease ( elevated tissue transglutaminase antibody ) 3 . Inability provide inform consent unwilling participate 4 . Evidence untreated infection e.g . clostridium difficile 5 . Presence stoma J pouch 6 . Presence enterocutaneous , abdominal pelvic fistula abscesses fistulae likely require surgery study period 7 . Bowel surgery within 12 week prior screen and/or surgery plan deem likely IBD study period 8 . Fixed symptomatic stenosis small bowel colon 9 . Chronic use narcotic chronic pain define daily use one dose narcotic contain medication 10 . Use oral intravenous antibiotic within 4 week prior screen 11 . Use tube enteral feeding , elemental diet , parenteral alimentation within 2 week prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>